Ethyl 6-formylpyridine-2-carboxylate, 95.0%, 100mg

2-Bromo-1-(2-bromoethyl)-4-chlorobenzene, 95.0%, 5g

Nonanoic acid, 8-methyl-, (4-hydroxy-3-methoxyphenyl)methyl ester, 98%, 1mg

2-Amino-4-hydroxybenzothiazole, 95.0%, 5g

(2R,3S,4S,5R)-2-(Acetoxymethyl)-2-azido-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate, 95%, 50mg

(1-Methyl-1,2,3,6-tetrahydropyridin-3-yl)methanol, 98%, 1g

tetra-Natriumdiphosphat-Decahydrat, min. 98 %, reinst, 2.5 kg, kunststoffverpackung.

3-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine, 95.0%, 1g

1,8-Naphthyridine-3-carboxylic acid, 95.0%, 1g

6-Chloro-2,2'-bipyridine, 95.0%, 1g

2-(4-(Bromomethyl)-2-chlorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

2,3-Dibromoquinoline, 97%, 1g

5-Bromo-1,3-dichloro-2-methoxybenzene, 95.0%, 250mg